Literature DB >> 19542314

Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations.

Benoît Tyl1, Meriam Kabbaj, Basmah Fassi, Patrick De Jode, William Wheeler.   

Abstract

This study compares the ability of 2 semiautomated methods with a fully automated method for QT measurement to minimize the sample size required to detect a moxifloxacin effect and exclude a placebo effect in a thorough QT/QTc study. The fully automated and 1 of 2 semiautomated methods used a global QT measurement in 12 leads, whereas the other semiautomated method used a tangent method on single lead raw complexes. Mean QTcF intervals were greater when measured on a global QT electrocardiogram than on raw complexes, but the mean magnitudes of DeltaQTcF were similar for all methods. The 3 methods detected a statistically significant increase in QTcF for moxifloxacin compared to placebo and were able to exclude a placebo effect on QTcF in all 62 participants. However, due to a smaller variability, the semiautomated methods allowed these detections with fewer than 20 participants, whereas the fully automated required at least 27 participants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542314     DOI: 10.1177/0091270009337944

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  4 in total

1.  Man versus Machine: Comparison of Automated and Manual Methodologies for Measuring the QTc Interval: A Prospective Study.

Authors:  Jean T Barbey; Margaret Connolly; Brenda Beaty; Mori J Krantz
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-05-04       Impact factor: 1.468

2.  Comparing QT interval variability of semiautomated and high-precision ECG methodologies in seven thorough QT studies-implications for the power of studies intended for definitive evaluation of a drug's QT effect.

Authors:  Karin Meiser; Pierre Jordaan; Sasha Latypova; Borje Darpo
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-12-19       Impact factor: 1.468

Review 3.  Early investigation of QTc liability: the role of multiple ascending dose (MAD) study.

Authors:  Rashmi R Shah; Joel Morganroth
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

4.  Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study.

Authors:  Rashmi R Shah; Pierre Maison-Blanche; Thierry Duvauchelle; Philippe Robert; Emmanuel Denis
Journal:  Eur J Clin Pharmacol       Date:  2015-10-01       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.